Whole-body metabolic tumor volume, as determined by FDG-PET/CT before treatment, is a reliable prognosticator of overall survival in patients who have invasive ductal carcinoma (IDC) of the breast and distant metastases at the time of their initial diagnosis, according to a study published online July 23 in theAmerican Journal of Roentgenology. {read more here}